The HPV vaccine has failed to gain market share compared to other new vaccines, even though it’s great at preventing cancer. Concerns about teen promiscuity and attempts to require it may be why.
The HPV vaccine has failed to gain market share compared to other new vaccines, even though it’s great at preventing cancer. Concerns about teen promiscuity and attempts to require it may be why.